HeartFlow Analysis vs Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) offers superior usability by integrating directly into routine physical exams via digital stethoscopes, providing rapid results in approximately 15 seconds. This point-of-care application makes it highly accessible for early detection in a broad clinical context. HeartFlow Analysis, while providing detailed insights, requires a separate and more complex CT imaging procedure.

HeartFlow Analysis provides a deeper, more definitive diagnostic and prognostic assessment for coronary artery disease through personalized 3D models, FFRct, and plaque analysis, which can significantly impact treatment decisions and potentially avoid unnecessary invasive procedures. It is recognized in major cardiology guidelines. While ELEFT offers valuable early screening for heart failure, HeartFlow's detailed physiological and anatomical assessment for CAD represents a higher level of clinical impact for definitive diagnosis and treatment planning.

HeartFlow Analysis has a clear advantage with established Category I CPT codes (75580, 75577 for 2026) and confirmed coverage by Medicare and most U.S. commercial payers. This transparent and established reimbursement pathway significantly enhances its value proposition for healthcare providers. ELEFT's pricing and reimbursement details are less transparent, requiring direct vendor contact.

Eko Low Ejection Fraction Tool (ELEFT), as part of the SENSORAu2122 platform, explicitly offers robust enterprise features such as Single Sign-On (SSO), an Admin Dashboard for centralized data management, on-site training, and dedicated customer success managers with EHR customization. While HeartFlow is used in many hospitals and meets high security standards, Eko's SENSORAu2122 platform is specifically designed with a comprehensive suite of enterprise-level integrations and support services.

HeartFlow Analysis demonstrates greater innovation through its sophisticated application of AI and computational fluid dynamics (CFD) to create personalized 3D models and simulate blood flow for FFRct and plaque analysis. This represents a groundbreaking advancement in non-invasive cardiovascular diagnostics. ELEFT's innovation lies more in its accessible point-of-care application rather than the fundamental scientific novelty of its AI algorithms.

Eko Health provides comprehensive and clearly outlined support and documentation, including a Help Center with user manuals and FAQs, live demos, scheduled calls, and a support ticket system with specified response times. For enterprise clients, Eko offers dedicated VIP customer support and on-site training. HeartFlow mentions regional support specialists and interactive documentation, but Eko's offerings appear more structured and publicly detailed across various support channels.